Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 25 June, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Lincoln Pharmaceuticals Ltd

About the Company - Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 472.08 Cr. and Equity Capital is Rs. 20.03 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsLincoln House, Ahmedabad Gujarat 380060investor@lincolnpharma.com
http://www.lincolnpharma.com
Management
NamePosition Held
Mr. Kishor M ShahChairman
Mr. Mahendra G PatelManaging Director
Mr. Hashmukh I PatelWhole Time Director
Mr. Munjal M PatelWhole Time Director
Mr. Ashish R PatelWhole Time Director
Mr. Rajnikant G PatelNon Executive Director
Mr. Meha M PatelIndependent Director
Mr. Saurin J ParikhIndependent Director
Mr. Pirabhai R SutharIndependent Director

Basic Stock Data of Lincoln Pharmaceuticals Ltd

Last Updated: June 17, 2024, 8:26 pm

Market Cap 1,233 Cr.
Current Price 616
High / Low755/386
Stock P/E13.2
Book Value 296
Dividend Yield0.24 %
ROCE22.5 %
ROE17.0 %
Face Value 10.0
PEG Ratio1.19

Competitors of Lincoln Pharmaceuticals Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Jubilant Pharmova Ltd 12,047 Cr. 756775/319295 3410.66 %6.74 %0.76 % 1.00
Brooks Laboratories Ltd 237 Cr. 90.2186/72.5 25.00.00 %24.7 %28.1 % 10.0
Bharat Immunological & Biological Corporation Ltd 130 Cr. 30.143.9/20.5 18.20.00 %9.27 %17.7 % 10.0
Alembic Ltd 2,886 Cr. 112117/71.010.7 85.11.96 %4.86 %12.6 % 2.00
Astrazeneca Pharma India Ltd 15,964 Cr. 6,3857,221/3,650107 2850.25 %31.1 %23.0 % 2.00
Industry Average15,500.37 Cr1,225.5538.69194.850.36%17.26%16.70%6.46

Lincoln Pharmaceuticals Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales11580122127120103123141134112136156146
Expenses95649798968510711210796115125117
Operating Profit20152529231717292717213130
OPM %17%19%21%23%20%17%14%21%20%15%15%20%20%
Other Income13233266648911
Interest0100010001000
Depreciation2222222222333
Profit before tax18152531241721323117253738
Tax %27%18%29%25%25%34%28%26%29%26%25%25%26%
Net Profit13131823181115242213192828
EPS in Rs6.746.298.8511.528.795.507.4911.8410.796.279.4913.8014.00

Last Updated: June 7, 2024, 9:03 am

Lincoln Pharmaceuticals Ltd Quarterly Chart

Lincoln Pharmaceuticals Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales188195210266400360361366386424472510551
Expenses174179190240359313308299321337376421452
Operating Profit14162026414753686687969098
OPM %7%8%10%10%10%13%15%18%17%21%20%18%18%
Other Income36277255115102231
Interest88781075422122
Depreciation23455667788910
Profit before tax711122033374662678496100117
Tax %30%16%16%24%28%25%25%22%23%26%28%27%
Net Profit5101015242835495162697387
EPS in Rs3.145.926.539.2014.5214.0617.3124.3625.7231.1234.6336.4043.56
Dividend Payout %19%10%9%11%7%9%9%6%6%5%4%4%

Lincoln Pharmaceuticals Ltd Profit & Loss Yearly Chart

Lincoln Pharmaceuticals Ltd Growth

Compounded Sales Growth
10 Years:11%
5 Years:10%
3 Years:11%
TTM:14%
Compounded Profit Growth
10 Years:25%
5 Years:14%
3 Years:14%
TTM:29%
Stock Price CAGR
10 Years:31%
5 Years:30%
3 Years:25%
1 Year:50%
Return on Equity
10 Years:17%
5 Years:17%
3 Years:17%
Last Year:17%

Last Updated: June 17, 2024, 9:13 pm

Lincoln Pharmaceuticals Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital16161616162020202020202020
Reserves64738295117172204249293346413482526
Borrowings657668767864613451221
Other Liabilities667293706448626371859983116
Total Liabilities212237260258275305347366389452534587663
Fixed Assets3865656698103117121123111132151147
CWIP142233702021679
Investments0000010111834819791132
Other Assets161169192190174186219225232259290339375
Total Assets212237260258275305347366389452534587663

Lincoln Pharmaceuticals Ltd Reserves and Borrowings Chart

Lincoln Pharmaceuticals Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 12-165254525275375697639
Cash from Investing Activity -27-1617-42-25-12-18-31-64-78-37
Cash from Financing Activity 1629-11-32-30-11-36-38-6-3-4
Net Cash Flow1-3-4-1-0-03-17-1-4-2

Lincoln Pharmaceuticals Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days127140154163739211112296989098
Inventory Days64546244366386759586121106
Days Payable125133174924054829210210512077
Cash Conversion Cycle66624311670100115106887891126
Working Capital Days90849714579115138143130119115123
ROCE %10%11%11%15%22%19%19%23%22%25%24%22%

Lincoln Pharmaceuticals Ltd Financial Efficiency Indicators Chart

Lincoln Pharmaceuticals Ltd Share Holding Pattern

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Promoters33.41%37.26%37.78%40.28%42.08%42.05%44.08%44.09%46.34%47.00%48.68%50.53%
FIIs0.00%0.00%0.01%0.75%0.95%0.77%0.64%0.63%1.44%1.27%1.74%2.59%
Public66.59%62.74%62.21%58.97%56.97%57.19%55.28%55.29%52.22%51.74%49.57%46.87%
No. of Shareholders19,97721,41526,42030,27431,91332,44731,90231,73129,84629,08827,48028,670

Lincoln Pharmaceuticals Ltd Shareholding Pattern Chart

No. of Lincoln Pharmaceuticals Ltd Shareholders

Lincoln Pharmaceuticals Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Motilal Oswal S&P BSE Healthcare ETF1060.080.011062024-06-200%

Lincoln Pharmaceuticals Ltd ROCE Trend

Lincoln Pharmaceuticals Ltd EPS Trend

Lincoln Pharmaceuticals Ltd Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)46.5836.4034.6331.1125.72
Diluted EPS (Rs.)46.5836.4034.6331.1125.72
Cash EPS (Rs.)51.8940.9738.6634.9129.40
Book Value[Excl.RevalReserv]/Share (Rs.)295.98250.86216.12187.85156.74
Book Value[Incl.RevalReserv]/Share (Rs.)295.98250.86216.12187.85156.74
Revenue From Operations / Share (Rs.)289.84254.78235.71212.09193.25
PBDIT / Share (Rs.)67.0755.7652.6646.4238.29
PBIT / Share (Rs.)61.7651.1848.6242.6434.63
PBT / Share (Rs.)61.0350.1647.9041.8633.62
Net Profit / Share (Rs.)46.5836.4034.6331.1225.73
NP After MI And SOA / Share (Rs.)46.5836.4034.6331.1125.72
PBDIT Margin (%)23.1321.8822.3421.8819.81
PBIT Margin (%)21.3020.0820.6220.1017.91
PBT Margin (%)21.0519.6820.3219.7317.39
Net Profit Margin (%)16.0714.2814.6914.6713.31
NP After MI And SOA Margin (%)16.0714.2814.6914.6613.30
Return on Networth / Equity (%)15.7314.5016.0216.5816.42
Return on Capital Employeed (%)20.3419.8921.9422.1021.38
Return On Assets (%)13.3212.4112.9713.5413.21
Total Debt / Equity (X)0.000.000.000.000.01
Asset Turnover Ratio (%)0.900.900.950.991.03
Current Ratio (X)4.845.083.904.173.78
Quick Ratio (X)4.004.113.103.533.06
Inventory Turnover Ratio (X)2.732.482.662.182.76
Dividend Payout Ratio (NP) (%)0.004.124.320.0011.66
Dividend Payout Ratio (CP) (%)0.003.663.870.0010.21
Earning Retention Ratio (%)0.0095.8895.680.0088.34
Cash Earning Retention Ratio (%)0.0096.3496.130.0089.79
Interest Coverage Ratio (X)91.7055.0172.6859.4437.95
Interest Coverage Ratio (Post Tax) (X)64.6936.9148.7940.8626.51
Enterprise Value (Cr.)1159.77646.08574.49436.11258.08
EV / Net Operating Revenue (X)2.001.271.221.030.66
EV / EBITDA (X)8.635.795.454.703.37
MarketCap / Net Operating Revenue (X)2.021.331.321.060.69
Retention Ratios (%)0.0095.8795.670.0088.33
Price / BV (X)1.981.351.441.200.85
Price / Net Operating Revenue (X)2.021.331.321.060.69
EarningsYield0.070.100.110.130.19

Lincoln Pharmaceuticals Ltd Profitability Ratios (%)

Lincoln Pharmaceuticals Ltd Liquidity Ratios

Lincoln Pharmaceuticals Ltd Liquidity Ratios (%)

Lincoln Pharmaceuticals Ltd Interest Coverage Ratios (%)

Lincoln Pharmaceuticals Ltd Valuation Ratios

Fair Value

Fair Value: 665.82

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 8.09% compared to the current price 616

Intrinsic Value: 739.81

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 20.10% compared to the current price ₹616

Last 5 Year EPS CAGR: 11.11%

*Investments are subject to market risks

Strength and Weakness of Lincoln Pharmaceuticals Ltd Stock

StrengthWeakness
  1. The stock has a high average ROCE of 18.58%, which is a positive sign.
  2. The company has higher reserves (239.69 cr) compared to borrowings (41.00 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (360.69 cr) and profit (53.23 cr) over the years.
  1. The stock has a high average Working Capital Days of 114.83, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 88.42, which may not be favorable.

FAQ

What is the latest fair value of Lincoln Pharmaceuticals Ltd?

The latest fair value of Lincoln Pharmaceuticals Ltd is ₹665.82.

What is the Market Cap of Lincoln Pharmaceuticals Ltd?

The Market Cap of Lincoln Pharmaceuticals Ltd is 1,233 Cr..

What is the current Stock Price of Lincoln Pharmaceuticals Ltd as on 22 June 2024?

The current stock price of Lincoln Pharmaceuticals Ltd as on 22 June 2024 is ₹616.

What is the High / Low of Lincoln Pharmaceuticals Ltd stocks in FY 2024?

In FY 2024, the High / Low of Lincoln Pharmaceuticals Ltd stocks is 755/386.

What is the Stock P/E of Lincoln Pharmaceuticals Ltd?

The Stock P/E of Lincoln Pharmaceuticals Ltd is 13.2.

What is the Book Value of Lincoln Pharmaceuticals Ltd?

The Book Value of Lincoln Pharmaceuticals Ltd is 296.

What is the Dividend Yield of Lincoln Pharmaceuticals Ltd?

The Dividend Yield of Lincoln Pharmaceuticals Ltd is 0.24 %.

What is the ROCE of Lincoln Pharmaceuticals Ltd?

The ROCE of Lincoln Pharmaceuticals Ltd is 22.5 %.

What is the ROE of Lincoln Pharmaceuticals Ltd?

The ROE of Lincoln Pharmaceuticals Ltd is 17.0 %.

What is the Face Value of Lincoln Pharmaceuticals Ltd?

The Face Value of Lincoln Pharmaceuticals Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Lincoln Pharmaceuticals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE